Digital humans represent the next stage in the evolution of “conversational AI”, a branch of artificial intelligence focused on understanding and responding to human language. Conceptual descendents of the humble chatbot, digital humans are capable of interpreting both spoken and nonverbal language, like body language and tone of voice, understanding context, and even interpreting emotional cues.
Paired with life-like, highly emotive, digitally animated human faces, digital humans are already being used by companies to provide a wide range of services to customers and employees. They have been built from the ground-up to be cheap and scalable, and to integrate easily with existing data structures and digital platforms.
To truly benefit from the use of digital humans in Pharma, however, businesses must understand their strengths and limitations, and especially how best to implement them. In this article, I explain what digital humans are and how they work, examine use cases in Pharma (and beyond), and cover three key steps for proper implementation.
What are digital humans and how do they work?
Digital humans are a type of “conversational” artificial intelligence, so called because they are designed to understand and respond to humans in a conversational fashion. In other words, in plain, spoken language.
However, there are few key characteristics that set them apart from more basic kinds of conversational AI, like early-generation chatbots.
First, they are able to understand both verbal and nonverbal forms of communication. Thus, a digital human analyzes not only what you’ve said—but how you said it, the expression on your face, and the position of your body. This gives digital humans the ability to interpret, understand and respond to emotional cues, and an emphasis on emotional intelligence has been central to the development of digital humans.
Next, digital humans excel at understanding context and lexical semantics. The best-in-class conversational AI Amelia, for example, exhibits deep contextual understanding, such that the order of information or the presence of multiple or conditional meanings is interpreted correctly. Amelia also features intelligent context switching, so that switching from questions on, say, how much a drug costs to known interactions to existing biosimilars doesn’t cause it confusion.
Third, digital humans are able to intelligently with structured or unstructured information and provide reasoned, intelligent responses to queries. Commercially available digital humans on the market today have been built to “plug and play” with virtually any dataset on the planet, be that patient medical records, a comprehensive drug interaction database, or practitioner customer data.
Finally, digital humans are usually paired with a digital “avatar” — an expressive, animated, three-dimensional face on the screen. Advances in 3D rendering, paired with the impressive computing power of modern devices like smartphones and laptop computers, has made it possible for digital humans to wear photo-realistic faces that can smile, frown, nod and everything in between. Presented with such a life-like interlocutor, humans tend to be more engaged, more trusting, and more satisfied with their digital interactions.
Digital humans vs chatbots
Digital humans are often seen as the successors of chatbots, and while that may be true in some sense, there are significant conceptual differences.
Think of it this way: chatbots are a bit like those old cars on a track they have at amusement parks. They can go forward and back, speed up and slow down… but the route itself is fixed. This is because chatbots are largely pre-scripted and pre-programmed. True, decision trees allow for some flexibility, but it’s not an inherently scalable model. And when a human says something unexpected, the car, frustratingly, is prone to stall (not a great customer experience).
Digital humans are more like an autonomous car with GPS. They can take you from some starting point—a request or query—and figure out a path from A to B to satisfy that request. It may require making a few turns, getting onto the freeway, or even making a quick U-turn if you just realized you forgot something back home. Rather than running on a track, digital humans are able to understand an objective and seek out the appropriate solution.
In terms of customer experience, it’s night and day.
Benefits of using digital humans
There are a number of benefits to adding digital humans to your business. They are very cheap, compared to equivalent human labor, especially when one considers that digital humans are always on, always available, and do not fatigue. They are easily scalable, and can serve five, five hundred or five thousand customers, provided sufficient computing power is at hand.
As mentioned above, commercially available digital humans are able to “plug into” APIs, databases and data lakes. Amelia, a digital human from the company Amelia.ai, can “connect to any system that has an API” and “run on any device that has a web browser, as well as in native mobile apps.” In a way, it’s like being able to transform any dataset into an interactive, intelligent, digital representative.
As an artificial intelligence deeply rooted in machine learning and natural language processing, digital humans are capable of learning from past experiences. Thus, they get better and better at whatever interactions they have been assigned to, be they practitioner- or patient-facing, clinical or marketing, internal or external.
Finally, many early adopters of digital humans have reported significantly improved customer satisfaction rates as a direct result of their implementation. Improved, even, from human customer service interactions. For example, Bank of America reduced their call center staff by 50% with a digital human and subsequently achieved higher customer satisfaction scores using the digital human rather than humans.
How can digital humans be used in Pharma?
Above, I evoked the notion that a digital human is a bit like imbuing a database with the ability to listen and intelligently respond to queries. Thus, any role where a human would normally interpret a query, go to a data source, and find the answer, a digital human can do quite well. This covers a wide range of roles in Pharma and beyond, including:
- Customer service centers
- Medical information centers
- Patient support
- Practitioner support
- IT support
- Legal support
- HR support
Some of these are internal, like HR and IT support, while others are customer-facing, like practitioner and patient support.
Let’s take practitioner support as an example. It’s an ideal role for a digital human. We already know that practitioners want more sophisticated ways of accessing drug information in a way, but which are still user-friendly and enjoyable. Imagine a physician being able to tap on their screen at any time and say, “Can you let me know of any known interactions with this drug I’m about to prescribe, as well as its efficacy in adults aged 55 to 65 with congestive heart failure, and any alternatives if my patient is taking Doxorubicin?”
Digital humans are also adept at taking in information and recording it. Thus, they can be used to ease the tasks of:
- Enrolling patients in clinical trials
- Enrolling patients in market research
- Conducting market research via surveys, polling, and social media listening
Will digital humans replace jobs in Pharma?
Some of them, yes. Tasks related to information retrieval and presentation or information intake and recording are done very effectively by digital humans.
However, humans are still better, by and large, at strategy and high-level decision making, reacting intelligently to changes in markets and politics—all those tasks that marry cognition, creativity, intuition, and experience, will likely remain human for a while to come. This is largely a positive thing: it means that humans will be freed up to engage in more challenging and interesting tasks, those that determine the overall direction of a department or company, while digital humans tend to everyday queries and simple customer-facing experiences.
Three key steps to success with digital humans
We’ve seen that digital humans hold great potential for businesses when implemented correctly—but how can pharmaceutical companies be sure of doing so?
In my experience, there are three key factors that determine success in adding digital humans (or any AI).
First, understand the business problem you’re trying to solve. Technology is a tool, and businesses should be wary of making big investments in AI with the hopes that it will magically transform customer experiences or business processes. The potential is certainly there, but companies should connect their implementation to some specific business problem or objective. This is an essential first step, as it provides a framework for implementation and decision-making downstream.
Next, be sure you understand the target audience, whether that’s your customer or your own employees. What does this person need to achieve or accomplish and how, if at all, will a digital human help them to do so? What kind of interactions are they likely to have and in what emotional state? Servicing a busy practitioner, a sick and worried patient, and a confused employee are very different scenarios.
And finally, find the right digital human for the job. A + B = C; if you don’t have a clear business problem and a solid understanding of the audience, you won’t be able to do this. Once you do, however, you can comfortably compare vendors to determine which best fits your use cas
Conclusion
Digital humans are a sophisticated type of conversational AI that can interpret human communication in multiple forms, be they verbal or nonverbal. Affordable, scalable, intelligent, and adaptive, they serve as an emotive, lifelike digital personality for datasets of all kinds, making them ideal for any number of tasks. Successful implementation depends on understanding key business and audience factors, which should be carefully considered.
Found this article interesting?
At Eularis, we are here to ensure that AI and FutureTech underpins your pharma success in the way you anticipate it can, helping you achieve AI and FutureTech maturation and embedding it within your organisational DNA.
If you need help to leverage AI to identify how to leverage generative AI into your leadership plan to increase operational efficiencies and speed up revenue growth, then contact us to find out more.
We are also the leaders in creating future-proof strategic AI blueprints for pharma and can guide you on your journey to creating real impact and success with AI and FutureTech in your discovery, R&D and throughout the biopharma value chain and help identify the optimal strategic approach that moves the needle. Our process ensures that you avoid bias as much as possible, and get through all the IT security, and legal and regulatory hurdles for implementing strategic AI in pharma that creates organizational impact. We also identify optimal vendors and are vendor-agnostic and platform-agnostic with a focus on ensuring you get the best solution to solve your specific strategic challenges. If you have a challenge and you believe there may be a way to solve it with AR but are not sure how, contact us for a strategic assessment.
See more about what we do in this area here.
Contact Dr Bates on Linkedin here.
Listen to the AI for Pharma Growth Podcast on
For more information, contact Dr Andree Bates abates@eularis.com.